在治疗不受控制的COPD时,医生决策的探索性研究
Kristin Kahle-Wrobleski1, Bonnie K H Bui2, Jennifer Friderici2
1US Value Evidence and Outcomes, GSK, Philadelphia, PA, USA.
医生对慢性阻塞性肺病 (COPD) 三重治疗的决定是复杂的. 诸如成本,获取和经验等因素影响了处方,尽管指南建议使用这些吸入器.
科学领域:
- 肺部医学 肺部医学
- 医疗保健管理的管理
背景情况:
- 目前的指导方针主张在慢性阻塞性肺病 (COPD) 患者中使用三重治疗吸入器.
- 在COPD管理中,推的维持疗法未得到充分利用是一个重大的临床挑战.
研究的目的:
- 调查医生关于COPD治疗的决策过程.
- 了解COPD联合维护疗法的实际使用模式.
主要方法:
- 在200名美国医生中进行了一项探索性,横截面的在线调查.
- 该调查采用了五个患者简历,并分析了影响治疗决策和处方障碍的因素.
- 多变量分析评估了切换到三重疗法的可能性与维持当前治疗的可能性.
主要成果:
- 治疗成本和患者获取被确定为处方的主要障碍.
- 医生更倾向于根据患者病史,保险和指导方针转向三重疗法.
- 医生在COPD方面的经验增加与处方三重治疗的可能性更高相关.
结论:
- 医生对COPD的处方涉及多方面的考虑,包括成本,获取,坚持,并发症,疗效,指南和经验.
- 需要进一步的研究来澄清这些因素的重要性,并开发有利于COPD治疗的决策支持工具.
更多相关视频
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
